CoLucid Pharmaceuticals' (CLCD) Price Target Raised to $52 at Ladenburg Thalmann

September 6, 2016 9:10 AM EDT
Get Alerts CLCD Hot Sheet
Price: $46.25 -0.11%

Rating Summary:
    4 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade CLCD Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Ladenburg Thalmann maintained a Buy rating on CoLucid Pharmaceuticals (NASDAQ: CLCD) and raised its price target to $52.00 (from $23.00)

For an analyst ratings summary and ratings history on CoLucid Pharmaceuticals click here. For more ratings news on CoLucid Pharmaceuticals click here.

Shares of CoLucid Pharmaceuticals closed at $10.66 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change, Trader Talk

Related Entities

Ladenburg Thalmann Financial Services

Add Your Comment